Friday - April 4, 2025
Agilent XCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
SANTA CLARA, California, March 25 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:

* * *

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Innovative technology supports testing of accuracy and reliability in Autolus Therapeutics' recently approved CAR T therapy AUCATZYL

Agilent Technologies Inc. (NYSE: A) is pleased to a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products